Tonix Pharma (TNXP) Tops Q2 EPS by 27c

Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($2.44), $0.27 better than the analyst estimate of ($2.71). Revenue for the quarter came in at $13.54 million versus the consensus estimate of $6.96 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• KeyBanc Starts PPG Industries (PPG) at Overweight
• RH (RH) Tops Q2 EPS by $2.31
• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance